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INTRODUCTION: 
Colon specific drug delivery has the advantage for 
effective treatment of various colon related diseases such 
as Colon cancer, Ulcerative colitis, inflammatory bowel 
disease, Crohn’s disease, infections etc. Further the colon 
is believed to be suitable absorption site for peptides and 
protein drugs due to relative low proteolytic enzyme 
activity, near neutral pH and a much longer transit period. 
Site-specific drug delivery to the colon is considered for 
the past few years in order to develop drug delivery 
systems that are able to release drugs specifically in the 
colon in a predictable and reproducible manner. The 
importance of site specific drug delivery to colon is for the 
treatment of diseases associated with the colon, reducing 
the side effects and reducing the dose. 
Various approaches like pH-dependent release, time-
dependent release and microbial enzyme triggered release. 
pH dependent systems have the disadvantage of specificity 
as there is minor change in variation in pH between small 
intestine and colon. The time dependent system has the 
limitation that the drug may be released in the small 
intestine with small variation of small intestine transit 
time. Recently microbial enzyme triggered approach based 
on polysaccharides have drawn much attention due to their 
degradation by colon microbial enzymes. Various 
polysaccharides like Guar gum, Chitosan, Pectin, Inulin 
etc. were used for colonic delivery of drug but with limited 
success. 
The aim of present investigation was to evaluate hibiscus 
gum as carrier for the formulation of colon specific drug 
delivery that offer protection of drug in the upper GIT and 
release it in the colon. Formulations like matrix tablets and 
tablet with hibiscus gum coating were studied to optimize 
the colon specific drug delivery of a model drug.[1-3] 
MATERIALS AND METHODS 
Materials: 
5-Fluorouracil  was a gift sample from Intas  
Pharmaceutical Ltd., Ahmedabad,India. MCC, lactose and 
other chemicals were obtained from CDH Chemical.  
Extraction of gum from Hibiscus esculentus: Hibiscus 
esculentus fruits were thoroughly washed with water, 
deseeded, crushed and soaked in water overnight. The gum 
solution was separated through the muslin cloth. The marc 
was again soaked in water overnight. The gum solution 
obtained was separated from marc by filtration and both 
the filtrates were mixed together. This gum solution was 
concentrated to half of its initial volume on a water bath. 
The crude gum was then precipitated with ethanol. 
Precipitates obtained were filtered and washed with 
ethanol. The gum was dried in oven at 45
0
C for 12 hours. 
The dried gum was purified by dissolving in purified water 
and then precipitated with ethanol The dried gum was 
treated with 0.3 N Ba(OH)2 – 5% aqueous ZnSO4.7H2O 
for deproteinization. The precipitates were dried in oven at 
45
0
C for 12 hours.[4-5] 
Characterization of Gum: 
The viscosity and pH of 0.5% w/v hibiscus gum solution 
were determined using digital pH meter and Ostwald’s 
viscometer respectively. Further the gum was 
characterized for IR spectra and swelling index. 
Preparation of Matrix Tablet: 
Matrix tablets of 5-fluorouracil were prepared by direct 
compression method using various concentrations of 
hibiscus gum, Microcrystalline cellulose, lactose, 
Magnesium stearate and talc as given in the table: 
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Table 1: Showing composition of Matrix tablet 
Formulation 5- fluorouracil  (mg) Hibiscus gum 
(mg) 
MCC (mg) Lactose 
(mg) 
Magnesium 
Stearate (mg) 
Talc 
(mg) 
F1 150 25 100 175 5 5 
F2 150 50 100 150 5 5 
F3 150 75 100 125 5 5 
F4 150 100 100 100 5 5 
F5 150 125 100 75 5 5 
F6 150 150 100 50 5 5 
F7 150 175 100 25 5 5 
 
Preparation of Film coated tablet of 5-fluorouracil: 
The selected batch of 5-fluorouracil tablets was further 
coated with 0.5% w/v solution of Hibiscus gum in water 
using PEG 400 as plasticizer. Different batches with varied 
amount of coating were made by varying duration of 
coating. 
Evaluation of Tablets: 
The prepared tablets were evaluated for hardness, weight 
variation, friability and drug content using standard 
methods.
7-9
 
In vitro release studies: The in vitro drug release from 
different batches were determined in dissolution test 
apparatus using different pH mediums like pH 1.2, 7.4 and 
6.8 buffers either in presence or absence of rat caecal 
content. The dissolution studies were carried out for first 2 
hours using pH 1.2 buffer. Then the dissolution medium 
was changed to phosphate buffer pH 7.4 and tested for 
drug release for 2 h as the average small intestinal transit 
time is about 2 h. After 3 hours the dissolution studies 
were carried out in pH 6.8 phosphate buffered saline for 
further 8 hours. The studies were also carried out in pH 6.8 
phosphate buffered saline  containing 2% w/v of rat caecal 
contents. As the caecum is naturally anaerobic, the 
experiment was carried out with continuous CO2 supply 
into the beaker. At various time intervals, 5 ml of the 
dissolution sample was withdrawn and was analyzed by 
UV Visible Spectrophotometer at 267 nm. 
RESULTS AND DISCUSSION 
Viscosity and Swelling properties: 
The viscosity of 0.5% w/v solution of Hibiscus gum was 
82 cps. The release rate from polymer gel is inversely 
proportional to the viscosity of the gel. As the hibiscus 
gum is highly viscous it showed more resistant to release 
of drug from the matrix. The pH of gum solution was 
found to be 6.5 which is slight acidic because of presence 
of uronic acid. Swelling index of the gum is about 200%  
for the first 1 hour and the maximum is 450% in 24 hours 
which showed hydrophilic nature of the gum.  
IR spectra of Hibiscus Gum: 
 The FTIR spectrum of pure gum is shown in Figure 1. The 
spectra showed a strong hydrogen bond O-H stretching at 
3403.4 cm
-1
 indicating presence of primary alcohol and O-
H of carboxylic acid. A C-H stretch at 2929.7 cm
-1
 showed 
the presence of -CH2 moieties in the sample. Peak at 
1652.6 cm
-1
 indicating the presence of C=O group in the 
gum. Peak of 1252.6 cm
-1
 showed C-O stretching and a 
bending band for O-H at 1419.3. Peak at 1042 cm
-1
 
indicated the presence of primary alcohol and also C-C 
stretching. 
 
 
Hardness of Matrix tablets: 
All the batches of matrix tablets showed hardness within 
prescribed  range of 5-6 except the formulation F7 in 
which the surface of the tablet is not smooth because of 
stickiness of hibiscus gum. The weight variation of 
different batches was within the limit. The drug content 
was found to be in the range of 98.55 to 99.45%. 
In vitro release studies: 
The in vitro release studies of 5-fluorouracil  from matrix 
tablets were shown in the figure 2. 
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Figure 2: Drug release profiles of 5-fluorouracil from Hibiscus gum matrix tablets 
From the release profile it was shown that the drug 
release decrease with the increase in the concentration of 
hibiscus gum and decrease in concentration of lactose 
which is soluble in water. Formulation F1 to F3 showed 
98.21%  to 45.74% drug release within first 4 hours and 
almost all the drug released within 10 hours. 
Formulation F5 and F6 showed less than 15% drug 
release within first 4 hours which was due to higher 
concentration hibiscus gum. So for coating the 
formulation F5 was selected. Formulation F5 coated with 
0.5% hibiscus gum solution was subjected to Drug 
release studies and the comparative release was showed 
in figure 3 
 
Figure 3: Comparative release profile of formulation F5 
with or without coating. 
From fig. 3 it was observed that the formulation F5 
coated with 0.5% hibiscus gum solution showed more 
resistance for the drug release. This may be due to 
formation of uniform protective layer membrane of 
polymer gel which refrain the release of drug.  
The release profile of formulation F5 (coated) with and 
without ceacal content was shown in Figure 4 
 
Figure 4:  Drug release profiles of 5-fluorouracil from 
coated formulation F5 with and without caecal content. 
From figure 4 it was observed that after 4 hrs when the 
formulation F5 (coated) was subjected to pH 6.8 buffer 
with 2% caecal content there occur abrupt release of 
drug from the formulation which showed microbial 
degradation of coating of hibiscus gum in the colonic 
fluid. 
CONCLUSION:  
Hibiscus gum controlled the release of 5-fluorouracil 
from the matrix tablet but its effectiveness increased 
when it was used as coating polymer. Further it was 
concluded that the release of drug from the matrix tablet 
is by microbial enzyme triggered mechanism. The study 
suggested that hibiscus gum may be an ideal candidate 
for the formulation of matrix tablet of as coating material 
for targeting drug to the colon.   
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